NRGSX | VEXPX | NRGSX / VEXPX | |
Total Expense Ratio | 0.74 | 0.44 | 168% |
Annual Report Gross Expense Ratio | 0.74 | 0.44 | 168% |
Fund Existence | 13 years | 58 years | - |
Gain YTD | -1.377 | 4.828 | -29% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.1B | 20.5B | 44% |
Annual Yield % from dividends | 0.06 | 0.39 | 16% |
Returns for 1 year | -0.74 | 2.32 | -32% |
Returns for 3 years | 5.81 | 19.05 | 31% |
Returns for 5 years | 8.51 | 14.43 | 59% |
Returns for 10 years | 13.99 | 31.38 | 45% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
USSH | 50.91 | N/A | N/A |
WisdomTree 1-3 Year Laddered Trsy ETF | |||
WINN | 30.76 | -0.02 | -0.07% |
Harbor Long-Term Growers ETF | |||
IBGB | 25.21 | -0.09 | -0.35% |
iShares iBonds Dec 2045 Term Trsy ETF | |||
KBA | 29.47 | -0.28 | -0.94% |
KraneShares Bosera MSCIChinaA50CntIdETF | |||
FMED | 24.58 | -0.30 | -1.21% |
Fidelity Disruptive Medicine ETF |